Gene · 27329
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypertriglyceridaemia-Associated Acute Pancreatitis: Risk Stratification, Drivers, and Prevention of Recurrence. | Diseases | 2026 | 41745085 | PubTator, text mining | PubMed |
| Target-stabilized base editors enable robust high-fidelity RNA editing. | Nat Commun | 2026 | 41741438 | PubTator, text mining | PubMed |
| From polygenic risk to digital twins: the future of personalised cardiovascular medicine. | Front Cardiovasc Med | 2026 | 41736831 | PubTator, text mining | PubMed |
| Advances in Engineered Virus-Like Particles for Genome Editing and Therapy. | BioDrugs | 2026 | 41733889 | PubTator, text mining | PubMed |
| Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy. | Expert Opin Drug Deliv | 2026 | 41729255 | PubTator, text mining | PubMed |
| Cell membranes-encapsulated gadolinium-doped carbon dots for the efficient photothermal and immunotherapeutic synergistic treatment of hepatocellular carcinoma. | J Nanobiotechnology | 2026 | 41723470 | PubTator, text mining | PubMed |
| Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies. | World J Cardiol | 2026 | 41694036 | PubTator, text mining | PubMed |
| Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review). | Int J Mol Med | 2026 | 41685581 | PubTator, text mining | PubMed |
| Advanced therapy in familial hypercholesterolemia. | Can Fam Physician | 2026 | 41679946 | PubTator, text mining | PubMed |
| Efficacy of evinacumab by genotype and low-density lipoprotein receptor function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study. | Atherosclerosis | 2026 | 41671678 | PubTator, text mining | PubMed |
| Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: an updated systematic review and meta-analysis. | Front Pharmacol | 2026 | 41669684 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| Olezarsen and Beyond: Emerging Targeted Treatments for Familial Chylomicronemia Syndrome and Related Triglyceride Disorders. | J Lipid Atheroscler | 2026 | 41660532 | PubTator, text mining | PubMed |
| Ultrasound-Enhanced Delivery of the Quercetin Derivative ANL3 Activates the FOXO1A-NDRG2-SOD2 Axis to Induce Endoplasmic Reticulum Stress in Osteosarcoma. | Cancer Biother Radiopharm | 2026 | 41642032 | PubTator, text mining | PubMed |
| ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer. | Cancer Res Commun | 2026 | 41627888 | PubTator, text mining | PubMed |
| A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol. | EBioMedicine | 2026 | 41619350 | PubTator, text mining | PubMed |
| Investigation of the relationship between carotid intima-media thickness and angiopoietin-like factor 3 levels in metabolic dysfunction-associated steatotic liver disease. | Sci Rep | 2026 | 41617820 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Abdominal Aortic Aneurysm. | Curr Atheroscler Rep | 2026 | 41615587 | PubTator, text mining | PubMed |
| Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress. | Cells | 2026 | 41597209 | PubTator, text mining | PubMed |
| Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias. | Int J Mol Sci | 2026 | 41596567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27329/papers?page=6